The Role of Revaprazan Hydrochloride in Pharmaceutical R&D
In the dynamic field of pharmaceutical research and development (R&D), the availability of high-quality chemical intermediates is paramount. Revaprazan Hydrochloride, identified by CAS number 178307-42-1, is a crucial compound that empowers R&D efforts focused on gastrointestinal therapies. As a leading pharmaceutical intermediate manufacturer based in China, we specialize in supplying Revaprazan HCl that meets the exacting standards of the R&D community.
Revaprazan Hydrochloride is a unique pharmaceutical intermediate known for its role in the synthesis of potent drugs that act as reversible proton pump inhibitors (PPIs) and acid pump antagonists. Its primary application lies in the treatment of gastrointestinal disorders, including gastric ulcers, duodenal ulcers, and gastritis. The compound's pharmacological profile, characterized by rapid action and reversible inhibition of gastric acid secretion, makes it an attractive target for drug development. For researchers, Revaprazan HCl serves as a foundational building block for exploring new therapeutic avenues.
The chemical identity of Revaprazan Hydrochloride is defined by its molecular formula C22H23FN4.HCl and a molecular weight of 398.90 g/mol. The purity of this intermediate is non-negotiable for successful R&D outcomes, which is why our manufacturing processes consistently yield Revaprazan HCl with a purity of ≥99%. This high purity ensures that research data is reliable and that scale-up processes are efficient, minimizing the risk of unexpected byproducts.
For R&D scientists and procurement specialists, sourcing Revaprazan HCl from reliable global manufacturers is a key consideration. We offer our product at competitive prices, supported by a robust supply chain that ensures timely delivery for your research projects. By choosing to buy Revaprazan Hydrochloride from our facility in China, you gain access to a quality-assured product backed by extensive manufacturing expertise. This allows you to focus on innovation rather than material sourcing challenges.
We are committed to supporting the pharmaceutical R&D ecosystem by providing access to essential chemical intermediates like Revaprazan Hydrochloride. Whether you are initiating early-stage research or scaling up for clinical trials, our team is prepared to meet your material needs. We encourage you to reach out for detailed product information, pricing inquiries, and to discuss how our Revaprazan HCl can facilitate your next breakthrough in gastrointestinal medicine.
Perspectives & Insights
Alpha Spark Labs
“The purity of this intermediate is non-negotiable for successful R&D outcomes, which is why our manufacturing processes consistently yield Revaprazan HCl with a purity of ≥99%.”
Future Pioneer 88
“This high purity ensures that research data is reliable and that scale-up processes are efficient, minimizing the risk of unexpected byproducts.”
Core Explorer Pro
“For R&D scientists and procurement specialists, sourcing Revaprazan HCl from reliable global manufacturers is a key consideration.”